Gilead Sciences Inc

GILD 
(NASDAQ) 
 
$ 62.36 <%= Resources.Global.txtDown %>
Updated 17:38:04
Change % -0.95% Stock price decreasing
Change -0.595 Stock price decreasing
Volume 1,971,953
High $ 63.33
Low $ 62.28
Open $ 62.78
ISIN
Prev close $ 62.95
# of shares 1,275.51M
Market cap 79,534M USD
Intraday

Gilead Sciences Inc
Market is open (until 21:00) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  62.36 -4.7% Stock price decreasing -2.2% Stock price decreasing -9.0% Stock price decreasing -13.8% Stock price decreasing -15.4% Stock price decreasing
Powered by TradingView

News about Gilead Sciences Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 73.65 -5.0% Stock price decreasing -5.5% Stock price decreasing 3.0% Stock price increasing 7.5% Stock price increasing 24.4% Stock price increasing 1.8% Stock price increasing
 
Bristol-Myers Squibb Company 45.19 -2.8% Stock price decreasing -6.2% Stock price decreasing -9.1% Stock price decreasing -11.2% Stock price decreasing -11.7% Stock price decreasing -13.1% Stock price decreasing
 
Merck & Company Inc (new) 72.99 -7.1% Stock price decreasing -11.3% Stock price decreasing -3.7% Stock price decreasing 0.6% Stock price increasing 24.1% Stock price increasing -4.5% Stock price decreasing
 
Pfizer Inc 38.94 -7.5% Stock price decreasing -7.0% Stock price decreasing -7.9% Stock price decreasing -12.2% Stock price decreasing 6.3% Stock price increasing -10.8% Stock price decreasing
 
Amgen Inc 176.92 -7.5% Stock price decreasing -5.2% Stock price decreasing -12.4% Stock price decreasing -10.7% Stock price decreasing 3.1% Stock price increasing -9.1% Stock price decreasing
 
Celgene Corporation 93.52 -1.7% Stock price decreasing 6.1% Stock price increasing 8.7% Stock price increasing 16.0% Stock price increasing 5.1% Stock price increasing 45.9% Stock price increasing
 
Novartis NAM SF 0,50 67.82 -5.1% Stock price decreasing -18.2% Stock price decreasing -12.9% Stock price decreasing -10.3% Stock price decreasing 6.6% Stock price increasing -8.8% Stock price decreasing
 
Roche Hldg AG GEN 233.05 -1.0% Stock price decreasing -2.7% Stock price decreasing 2.1% Stock price increasing 9.1% Stock price increasing 28.9% Stock price increasing 8.1% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,524.40 -1.7% Stock price decreasing -2.0% Stock price decreasing 2.3% Stock price increasing -1.0% Stock price decreasing 6.6% Stock price increasing 2.2% Stock price increasing
 
Sanofi 72.87 -2.8% Stock price decreasing -6.9% Stock price decreasing -0.4% Stock price decreasing -5.7% Stock price decreasing 11.6% Stock price increasing -3.7% Stock price decreasing
 
Biogen Inc 229.31 -1.3% Stock price decreasing 5.8% Stock price increasing -32.3% Stock price decreasing -27.3% Stock price decreasing -12.8% Stock price decreasing -23.8% Stock price decreasing

Company profile

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.

Peers

Instruments Last Change  
Abbott Labor.. 73.65 -0.4% Stock price decreasing
Bristol-Myer.. 45.19 -0.7% Stock price decreasing
Merck & Comp.. 72.99 -0.3% Stock price decreasing
Pfizer Inc 38.94 -1.1% Stock price decreasing
Amgen Inc 176.92 -0.3% Stock price decreasing
100,100,0,0,39,39,80,80,93,93
Celgene Corp.. 93.52 -0.3% Stock price decreasing
Novartis NAM.. 67.82 -1.8% Stock price decreasing
Roche Hldg A.. 233.05 -0.6% Stock price decreasing
Glaxosmithkl.. 1,524.40 -1.1% Stock price decreasing
Sanofi 72.87 -0.3% Stock price decreasing
Biogen Inc 229.31 0.0% Stock price unchanged

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 April 2019 17:53:28
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB1 - 2019-04-22 18:53:28 - 2019-04-22 17:53:28 - 1000 - Website: OKAY